Lysergic acid diethylamide (LSD)

URI: https://gptkb.org/entity/Lysergic_acid_diethylamide_(LSD)
GPTKB entity
Statements (52)
Predicate Object
gptkbp:instanceOf Hallucinogen
gptkbp:aroma odorless
gptkbp:ATCCode N01AX63
gptkbp:CASNumber 50-37-3
gptkbp:chemicalFormula C20H25N3O
gptkbp:color colorless
gptkbp:discoveredBy gptkb:Albert_Hofmann
gptkbp:discoveredIn 1938
gptkbp:duration_of_action 8–12 hours
gptkbp:effect anxiety
paranoia
euphoria
synesthesia
visual hallucinations
altered thoughts
gptkbp:eliminationHalfLife 3–5 hours
gptkbp:excretion urine
gptkbp:firstSynthesized gptkb:Sandoz_Laboratories
gptkbp:flavor slightly bitter
https://www.w3.org/2000/01/rdf-schema#label Lysergic acid diethylamide (LSD)
gptkbp:IUPACName (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
gptkbp:legalStatus gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
illegal in most countries
gptkbp:meltingPoint 80–85 °C
gptkbp:MeSH_ID D008093
gptkbp:metabolism liver
gptkbp:molecularWeight 323.43 g/mol
gptkbp:notableEvent central to 1960s counterculture
used in CIA MKUltra experiments
gptkbp:origin derived from ergot fungus
gptkbp:overdose_risk rare
gptkbp:PubChem_CID 5761
CHEBI:27927
DB04837
CHEMBL27
gptkbp:risk_of_dependence low
gptkbp:routeOfAdministration oral
intravenous
sublingual
gptkbp:solubility soluble in water
gptkbp:street_names gptkb:carboxylic_acid
blotter
dots
tabs
gptkbp:toxicity very low
gptkbp:UNII D839GV0YJ7
gptkbp:used_in spiritual practices
psychedelic therapy
recreational drug use
gptkbp:bfsParent gptkb:Schedule_III_(Canada)
gptkbp:bfsLayer 7